No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial (Q34220902)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial |
scientific article |
Statements
1 reference
No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial (English)
1 reference
Annelies Verbon
1 reference
Hanneke Schuitemaker
1 reference
Marlous L Grijsen
1 reference
Radjin Steingrover
1 reference
Ferdinand W N M Wit
1 reference
Kees Brinkman
1 reference
Marchina E van der Ende
1 reference
Robin Soetekouw
1 reference
Frank de Wolf
1 reference
Joep M A Lange
1 reference
Jan M Prins
1 reference
Primo-SHM Study Group
1 reference
27 March 2012
1 reference
1 reference
e1001196
1 reference
27 March 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference